A series of polymeric hemostatic materials are prepared in one-step, by using biobased lactic acid monomers and mature hemostatic drugs (4-aminomethylbenzoic acid or tranexamic acid) through direct melt polycondensation. These materials are powdery with rough and irregular surfaces, and the powder particle size is ~8–30 μm, which is beneficial to the application, immediate hemostasis and scab-bionic membrane forming. Moreover, after the degradation of these materials at 37 °C, more monomers will be released, resulting in a higher efficiency and long-term hemostatic function.
- Jian-Yun Lin
- Shi-He Luo
- Zhao-Yang Wang
